Home

Espinas vía fingir diffuse large b cell lymphoma prognosis calculator Gladys Melancólico heno

A new prognostic score for AIDS-related lymphomas in the rituximab-era |  Haematologica
A new prognostic score for AIDS-related lymphomas in the rituximab-era | Haematologica

International prognostic indices in diffuse large B-cell lymphoma: a  comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect

CNS International Prognostic Index: A Risk Model for CNS Relapse in  Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal  of Clinical Oncology
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP | Journal of Clinical Oncology

International prognostic indices in diffuse large B-cell lymphoma: a  comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect

Diffuse Large B-Cell Lymphoma Risk Score Calculator: A Tool To Accurat" by  Santosh Khanal, Arjun Gampala et al.
Diffuse Large B-Cell Lymphoma Risk Score Calculator: A Tool To Accurat" by Santosh Khanal, Arjun Gampala et al.

R/R International Prognostic Index (R/R‐IPI): An international prognostic  calculator for relapsed/refractory diffuse large B
R/R International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B

Progression-free survival at 24 months (PFS24) and subsequent outcome for  patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized  clinical trials - Annals of Oncology
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials - Annals of Oncology

Survival Rates and Factors That Affect Prognosis (Outlook) for Non-Hodgkin  Lymphoma
Survival Rates and Factors That Affect Prognosis (Outlook) for Non-Hodgkin Lymphoma

Relapsed/Refractory International Prognostic Index (R/R‐IPI): An  international prognostic calculator for relapsed/refractory diffuse large B‐cell  lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online  Library
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library

Relapsed/Refractory International Prognostic Index (R/R‐IPI): An  international prognostic calculator for relapsed/refractory diffuse large B‐cell  lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online  Library
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library

Diffuse Large B-Cell Lymphoma Prognosis (R-IPI) | QxMD
Diffuse Large B-Cell Lymphoma Prognosis (R-IPI) | QxMD

Frontiers | Development and Validation of a Novel Risk Stratification Model  for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma

A modified prognostic model in patients with diffuse large B‑cell lymphoma  treated with immunochemotherapy
A modified prognostic model in patients with diffuse large B‑cell lymphoma treated with immunochemotherapy

Novel prognostic scoring system for diffuse large B-cell lymphoma
Novel prognostic scoring system for diffuse large B-cell lymphoma

The Korean Journal of Internal Medicine
The Korean Journal of Internal Medicine

A model to predict the prognosis of diffuse large B-cell lymphoma based on  ultrasound images | Scientific Reports
A model to predict the prognosis of diffuse large B-cell lymphoma based on ultrasound images | Scientific Reports

Follicular Lymphoma International Prognostic Index (FLIPI). Online  calculator | ClinCaseQuest
Follicular Lymphoma International Prognostic Index (FLIPI). Online calculator | ClinCaseQuest

Prephase rituximab/prednisone therapy and aging-related, proinflammatory  cytokine milieu in older, vulnerable patients with newly diagnosed diffuse  large B-cell lymphoma | Haematologica
Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma | Haematologica

Diffuse Large B-cell Lymphoma Prognosis Calculator
Diffuse Large B-cell Lymphoma Prognosis Calculator

Comparative molecular cell-of-origin classification of diffuse large B-cell  lymphoma based on liquid and tissue biopsies | Translational Medicine  Communications | Full Text
Comparative molecular cell-of-origin classification of diffuse large B-cell lymphoma based on liquid and tissue biopsies | Translational Medicine Communications | Full Text

Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell  Lymphoma in the Era of the NCCN-IPI in: Journal of the National  Comprehensive Cancer Network Volume 13 Issue 12 (2015)
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI in: Journal of the National Comprehensive Cancer Network Volume 13 Issue 12 (2015)

A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell  Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the  Rituximab Era | Scientific Reports
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports

Gray Zone Lymphoma (GZL) with Features Intermediate between Classical Hodgkin  Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large  Retrospective. - ppt download
Gray Zone Lymphoma (GZL) with Features Intermediate between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective. - ppt download

Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma  Refractory to or in First Relapse After Initial R-CHOP Therapy: A  Single-Institution Study | Anticancer Research
Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution Study | Anticancer Research